Toronto Dominion Bank’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-14,400
Closed -$3.87M 1585
2023
Q3
$3.87M Buy
+14,400
New +$3.59M 0.01% 749
2019
Q2
Sell
-24,400
Closed -$4.64M 1450
2019
Q1
$4.64M Buy
+24,400
New +$4.66M 0.01% 702
2018
Q3
Sell
-31,000
Closed -$5.75M 1378
2018
Q2
$5.75M Buy
+31,000
New +$5.48M 0.01% 656

Other funds holding AMGN

Toronto Dominion Bank's AMGN Position: Q1 2026 in Review

Toronto Dominion Bank reduced its Amgen (AMGN) stake by 15% in Q1 2026, selling an estimated $10.5M and leaving 166,826 shares worth $58.7M. The position accounts for 0.08% of the portfolio, ranked #210.

Toronto Dominion Bank first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $173M in Q4 2021. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Toronto Dominion Bank held 166,826 shares of Amgen worth $58.7M as of Q1 2026.
  • Toronto Dominion Bank sold 29,460 Amgen shares in Q1 2026, an estimated $10.5M.
  • Amgen made up 0.08% of Toronto Dominion Bank's portfolio in Q1 2026, its #210 holding.
  • Toronto Dominion Bank first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • Toronto Dominion Bank's Amgen position peaked at $173M in Q4 2021.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.